WallStreetZenWallStreetZen

NYSE: CC
Chemours Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CC

Based on 8 analysts offering 12 month price targets for Chemours Co

Min Forecast
$13.00+18.4%
Avg Forecast
$17.63+60.52%
Max Forecast
$27.00+145.9%

Should I buy or sell CC stock?

Based on 8 analysts offering ratings for Chemours Co.

Buy
Strong Buy
2 analysts 25%
Buy
3 analysts 37.5%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CC as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CC stock forecasts and price targets.

CC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-28
lockedlocked$00.00+00.00%2025-05-14
lockedlocked$00.00+00.00%2025-05-12
lockedlocked$00.00+00.00%2025-05-08
lockedlocked$00.00+00.00%2025-05-07
Truist Securities
Bottom 9%
9
Strong BuyMaintains$22.00+100.36%2025-04-14
Mizuho
Top 9%
92
BuyUpgrades$19.00+73.04%2025-03-27
BMO Capital
Bottom 10%
10
BuyMaintains$27.00+145.90%2025-02-19

1 of 1

Forecast return on equity

Is CC forecast to generate an efficient return?

Company
70.12%
Industry
31.79%
Market
67.39%
CC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CC forecast to generate an efficient return on assets?

Company
5.49%
Industry
10.32%
CC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CC earnings per share forecast

What is CC's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$1.56+643.81%
Avg 2 year Forecast
$2.38+1,034.29%
Avg 3 year Forecast
$2.71+1,191.67%
CC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CC revenue forecast

What is CC's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$5.9B+0.91%
Avg 2 year Forecast
$6.1B+5.39%
Avg 3 year Forecast
$6.3B+8.52%
CC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CC earnings growth forecast

How is CC forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
225.53%
Industry
15.95%
Market
19.71%
CC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CC revenue growth forecast

How is CC forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
2.45%
Industry
2.78%
Market
9.85%
CC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CC vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
CC$10.98$17.63+60.52%Buy
MTX$54.11$80.00+47.85%Strong Buy
NGVT$42.01$51.50+22.59%Buy
PRM$13.15$15.50+17.87%Strong Buy
KWR$114.95$148.75+29.40%Buy
View Top Specialty Chemical Stocks

Chemours Co Stock Forecast FAQ

Is Chemours Co Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: CC) stock is to Buy CC stock.

Out of 8 analysts, 2 (25%) are recommending CC as a Strong Buy, 3 (37.5%) are recommending CC as a Buy, 3 (37.5%) are recommending CC as a Hold, 0 (0%) are recommending CC as a Sell, and 0 (0%) are recommending CC as a Strong Sell.

If you're new to stock investing, here's how to buy Chemours Co stock.

What is CC's earnings growth forecast for 2025-2027?

(NYSE: CC) Chemours Co's forecast annual earnings growth rate of 225.53% is forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 15.95%, and it is also forecast to beat the US market's average forecast earnings growth rate of 19.71%.

Chemours Co's earnings in 2025 is $31,000,000.On average, 5 Wall Street analysts forecast CC's earnings for 2025 to be $233,791,114, with the lowest CC earnings forecast at $202,060,182, and the highest CC earnings forecast at $299,348,418. On average, 5 Wall Street analysts forecast CC's earnings for 2026 to be $356,523,966, with the lowest CC earnings forecast at $305,335,386, and the highest CC earnings forecast at $423,578,011.

In 2027, CC is forecast to generate $405,991,292 in earnings, with the lowest earnings forecast at $363,708,328 and the highest earnings forecast at $493,924,890.

What is CC's revenue growth forecast for 2025-2027?

(NYSE: CC) Chemours Co's forecast annual revenue growth rate of 2.45% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Chemours Co's revenue in 2025 is $5,801,000,000.On average, 5 Wall Street analysts forecast CC's revenue for 2025 to be $876,202,697,984, with the lowest CC revenue forecast at $861,032,318,856, and the highest CC revenue forecast at $892,656,982,476. On average, 5 Wall Street analysts forecast CC's revenue for 2026 to be $915,059,769,056, with the lowest CC revenue forecast at $895,268,797,423, and the highest CC revenue forecast at $943,546,213,536.

In 2027, CC is forecast to generate $942,246,592,379 in revenue, with the lowest revenue forecast at $929,773,192,824 and the highest revenue forecast at $969,888,874,320.

What is CC's forecast return on assets (ROA) for 2025-2027?

(NYSE: CC) forecast ROA is 5.49%, which is lower than the forecast US Specialty Chemicals industry average of 10.32%.

What is CC's Price Target?

According to 8 Wall Street analysts that have issued a 1 year CC price target, the average CC price target is $17.63, with the highest CC stock price forecast at $27.00 and the lowest CC stock price forecast at $13.00.

On average, Wall Street analysts predict that Chemours Co's share price could reach $17.63 by May 28, 2026. The average Chemours Co stock price prediction forecasts a potential upside of 60.52% from the current CC share price of $10.98.

What is CC's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: CC) Chemours Co's current Earnings Per Share (EPS) is $0.21. On average, analysts forecast that CC's EPS will be $1.56 for 2025, with the lowest EPS forecast at $1.35, and the highest EPS forecast at $2.00. On average, analysts forecast that CC's EPS will be $2.38 for 2026, with the lowest EPS forecast at $2.04, and the highest EPS forecast at $2.83. In 2027, CC's EPS is forecast to hit $2.71 (min: $2.43, max: $3.30).

What is CC's forecast return on equity (ROE) for 2025-2027?

(NYSE: CC) forecast ROE is 70.12%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.